Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 59 entries
Sorted by: Best Match Show Resources per page
Comparison between the Effect of Cow Ghee and Butter on Memory and Lipid Profile of Wistar Rats.

Journal of clinical and diagnostic research : JCDR

Karandikar YS, Bansude AS, Angadi EA.
PMID: 27790463
J Clin Diagn Res. 2016 Sep;10(9):FF11-FF15. doi: 10.7860/JCDR/2016/19457.8512. Epub 2016 Sep 01.

INTRODUCTION: The traditional texts designate Cow Ghee as Medhya Rasayana, beneficial for mental alertness and memory. There has been concern about increased risk of cardiovascular disease due to its high percentage of saturated fatty acids in ghee. Amongst all...

Cite
Karandikar YS, Bansude AS, Angadi EA. Comparison between the Effect of Cow Ghee and Butter on Memory and Lipid Profile of Wistar Rats. J Clin Diagn Res. 2016;10(9):FF11-FF15doi: 10.7860/JCDR/2016/19457.8512.
Karandikar, Y. S., Bansude, A. S., & Angadi, E. A. (2016). Comparison between the Effect of Cow Ghee and Butter on Memory and Lipid Profile of Wistar Rats. Journal of clinical and diagnostic research : JCDR, 10(9), FF11-FF15. https://doi.org/10.7860/JCDR/2016/19457.8512
Karandikar, Yogita Surendra, et al. "Comparison between the Effect of Cow Ghee and Butter on Memory and Lipid Profile of Wistar Rats." Journal of clinical and diagnostic research : JCDR vol. 10,9 (2016): FF11-FF15. doi: https://doi.org/10.7860/JCDR/2016/19457.8512
Karandikar YS, Bansude AS, Angadi EA. Comparison between the Effect of Cow Ghee and Butter on Memory and Lipid Profile of Wistar Rats. J Clin Diagn Res. 2016 Sep;10(9):FF11-FF15. doi: 10.7860/JCDR/2016/19457.8512. Epub 2016 Sep 01. PMID: 27790463; PMCID: PMC5071963.
Copy Download .nbib Format: NLM
Non-Alcoholic Fatty Liver in Patients with Chylomicronemia.

Journal of clinical medicine

Maltais M, Brisson D, Gaudet D.
PMID: 33572376
J Clin Med. 2021 Feb 09;10(4). doi: 10.3390/jcm10040669.

Non-alcoholic fatty liver disease (NAFLD) is frequent in patients with features of the metabolic syndrome (MetS), obesity, or type 2 diabetes. Lipoprotein lipase (LPL) is the main driver of triglyceride (TG) hydrolysis in chylomicrons and very-low density lipoproteins (VLDL)....

Cite
Maltais M, Brisson D, Gaudet D. Non-Alcoholic Fatty Liver in Patients with Chylomicronemia. J Clin Med. 2021;10(4)doi: 10.3390/jcm10040669.
Maltais, M., Brisson, D., & Gaudet, D. (2021). Non-Alcoholic Fatty Liver in Patients with Chylomicronemia. Journal of clinical medicine, 10(4), . https://doi.org/10.3390/jcm10040669
Maltais, Mélanie, et al. "Non-Alcoholic Fatty Liver in Patients with Chylomicronemia." Journal of clinical medicine vol. 10,4 (2021). doi: https://doi.org/10.3390/jcm10040669
Maltais M, Brisson D, Gaudet D. Non-Alcoholic Fatty Liver in Patients with Chylomicronemia. J Clin Med. 2021 Feb 09;10(4). doi: 10.3390/jcm10040669. PMID: 33572376; PMCID: PMC7916177.
Copy Download .nbib Format: NLM
Effects of inflammation and soluble epoxide hydrolase inhibition on oxylipin composition of very low-density lipoproteins in isolated perfused rat livers.

Physiological reports

Walker RE, Savinova OV, Pedersen TL, Newman JW, Shearer GC.
PMID: 33625776
Physiol Rep. 2021 Feb;9(4):e14480. doi: 10.14814/phy2.14480.

Oxylipins are metabolites of polyunsaturated fatty acids that mediate cardiovascular health by attenuation of inflammation, vascular tone, hemostasis, and thrombosis. Very low-density lipoproteins (VLDL) contain oxylipins, but it is unknown whether the liver regulates their concentrations. In this study,...

Cite
Walker RE, Savinova OV, Pedersen TL, et al. Effects of inflammation and soluble epoxide hydrolase inhibition on oxylipin composition of very low-density lipoproteins in isolated perfused rat livers. Physiol Rep. 2021;9(4):e14480doi: 10.14814/phy2.14480.
Walker, R. E., Savinova, O. V., Pedersen, T. L., Newman, J. W., & Shearer, G. C. (2021). Effects of inflammation and soluble epoxide hydrolase inhibition on oxylipin composition of very low-density lipoproteins in isolated perfused rat livers. Physiological reports, 9(4), e14480. https://doi.org/10.14814/phy2.14480
Walker, Rachel E, et al. "Effects of inflammation and soluble epoxide hydrolase inhibition on oxylipin composition of very low-density lipoproteins in isolated perfused rat livers." Physiological reports vol. 9,4 (2021): e14480. doi: https://doi.org/10.14814/phy2.14480
Walker RE, Savinova OV, Pedersen TL, Newman JW, Shearer GC. Effects of inflammation and soluble epoxide hydrolase inhibition on oxylipin composition of very low-density lipoproteins in isolated perfused rat livers. Physiol Rep. 2021 Feb;9(4):e14480. doi: 10.14814/phy2.14480. PMID: 33625776; PMCID: PMC7903942.
Copy Download .nbib Format: NLM
Application of enzymatic fluorometric assays to quantify phosphatidylcholine, phosphatidylethanolamine and sphingomyelin in human plasma lipoproteins.

Chemistry and physics of lipids

Tsuji T, Yuri T, Terada T, Morita SY.
PMID: 34102186
Chem Phys Lipids. 2021 Aug;238:105102. doi: 10.1016/j.chemphyslip.2021.105102. Epub 2021 Jun 05.

Phosphatidylcholine (PC), phosphatidylethanolamine (PE) and sphingomyelin (SM) are important surface components of plasma lipoproteins, including very-low-density lipoproteins (VLDL), low-density lipoproteins (LDL) and high-density lipoproteins (HDL). However, the pathophysiological roles of PC, PE and SM in lipoproteins have not been...

Cite
Tsuji T, Yuri T, Terada T, et al. Application of enzymatic fluorometric assays to quantify phosphatidylcholine, phosphatidylethanolamine and sphingomyelin in human plasma lipoproteins. Chem Phys Lipids. 2021;238:105102doi: 10.1016/j.chemphyslip.2021.105102.
Tsuji, T., Yuri, T., Terada, T., & Morita, S. Y. (2021). Application of enzymatic fluorometric assays to quantify phosphatidylcholine, phosphatidylethanolamine and sphingomyelin in human plasma lipoproteins. Chemistry and physics of lipids, 238105102. https://doi.org/10.1016/j.chemphyslip.2021.105102
Tsuji, Tokuji, et al. "Application of enzymatic fluorometric assays to quantify phosphatidylcholine, phosphatidylethanolamine and sphingomyelin in human plasma lipoproteins." Chemistry and physics of lipids vol. 238 (2021): 105102. doi: https://doi.org/10.1016/j.chemphyslip.2021.105102
Tsuji T, Yuri T, Terada T, Morita SY. Application of enzymatic fluorometric assays to quantify phosphatidylcholine, phosphatidylethanolamine and sphingomyelin in human plasma lipoproteins. Chem Phys Lipids. 2021 Aug;238:105102. doi: 10.1016/j.chemphyslip.2021.105102. Epub 2021 Jun 05. PMID: 34102186.
Copy Download .nbib Format: NLM
Association between Non-HDL-C/HDL-C Ratio and Carotid Intima-Media Thickness in Post-Menopausal Women.

Journal of clinical medicine

Iannuzzi A, Giallauria F, Gentile M, Rubba P, Covetti G, Bresciani A, Aliberti E, Cuomo G, Panico C, Tripaldella M, Giusti MA, Mattina A, Iannuzzo G.
PMID: 35011818
J Clin Med. 2021 Dec 24;11(1). doi: 10.3390/jcm11010078.

Atherogenic lipoproteins (particularly, very low-density lipoproteins, VLDL) are associated with subclinical atherosclerosis. The present study aims at evaluating whether routinely analysed lipid parameters are associated with carotid intima-media thickness, a proxy for subclinical atherosclerosis. Lipid parameters from 220 post-menopausal...

Cite
Iannuzzi A, Giallauria F, Gentile M, et al. Association between Non-HDL-C/HDL-C Ratio and Carotid Intima-Media Thickness in Post-Menopausal Women. J Clin Med. 2021;11(1)doi: 10.3390/jcm11010078.
Iannuzzi, A., Giallauria, F., Gentile, M., Rubba, P., Covetti, G., Bresciani, A., Aliberti, E., Cuomo, G., Panico, C., Tripaldella, M., Giusti, M. A., Mattina, A., & Iannuzzo, G. (2021). Association between Non-HDL-C/HDL-C Ratio and Carotid Intima-Media Thickness in Post-Menopausal Women. Journal of clinical medicine, 11(1), . https://doi.org/10.3390/jcm11010078
Iannuzzi, Arcangelo, et al. "Association between Non-HDL-C/HDL-C Ratio and Carotid Intima-Media Thickness in Post-Menopausal Women." Journal of clinical medicine vol. 11,1 (2021). doi: https://doi.org/10.3390/jcm11010078
Iannuzzi A, Giallauria F, Gentile M, Rubba P, Covetti G, Bresciani A, Aliberti E, Cuomo G, Panico C, Tripaldella M, Giusti MA, Mattina A, Iannuzzo G. Association between Non-HDL-C/HDL-C Ratio and Carotid Intima-Media Thickness in Post-Menopausal Women. J Clin Med. 2021 Dec 24;11(1). doi: 10.3390/jcm11010078. PMID: 35011818.
Copy Download .nbib Format: NLM
Sirtuin 3 Restores Synthesis and Secretion of Very Low-Density Lipoproteins in Cow Hepatocytes Challenged with Nonesterified Fatty Acids In Vitro.

Veterinary sciences

Xing D, Wang B, Lu H, Peng T, Su J, Lei H, He J, Zhou Y, Liu L.
PMID: 34208809
Vet Sci. 2021 Jun 30;8(7). doi: 10.3390/vetsci8070121.

Fatty liver is closely associated with elevated concentrations of nonesterified fatty acids (NEFA) and a low level of very low-density lipoproteins (VLDL) in blood of dairy cows. High NEFA inhibit the VLDL synthesis and assembly, and cause hepatic triacylglycerol...

Cite
Xing D, Wang B, Lu H, et al. Sirtuin 3 Restores Synthesis and Secretion of Very Low-Density Lipoproteins in Cow Hepatocytes Challenged with Nonesterified Fatty Acids In Vitro. Vet Sci. 2021;8(7)doi: 10.3390/vetsci8070121.
Xing, D., Wang, B., Lu, H., Peng, T., Su, J., Lei, H., He, J., Zhou, Y., & Liu, L. (2021). Sirtuin 3 Restores Synthesis and Secretion of Very Low-Density Lipoproteins in Cow Hepatocytes Challenged with Nonesterified Fatty Acids In Vitro. Veterinary sciences, 8(7), . https://doi.org/10.3390/vetsci8070121
Xing, Dongmei, et al. "Sirtuin 3 Restores Synthesis and Secretion of Very Low-Density Lipoproteins in Cow Hepatocytes Challenged with Nonesterified Fatty Acids In Vitro." Veterinary sciences vol. 8,7 (2021). doi: https://doi.org/10.3390/vetsci8070121
Xing D, Wang B, Lu H, Peng T, Su J, Lei H, He J, Zhou Y, Liu L. Sirtuin 3 Restores Synthesis and Secretion of Very Low-Density Lipoproteins in Cow Hepatocytes Challenged with Nonesterified Fatty Acids In Vitro. Vet Sci. 2021 Jun 30;8(7). doi: 10.3390/vetsci8070121. PMID: 34208809; PMCID: PMC8310004.
Copy Download .nbib Format: NLM
DISTRIBUTION OF LIPID-SOLUBLE ANTIOXIDANTS IN LIPOPROTEINS FROM HEALTHY SUBJECTS. II. EFFECTS OF IN VIVO SUPPLEMENTATION WITH alpha-TOCOPHEROL.

Pharmacological research

Perugini C, Bagnati M, Cau C, Bordone R, Paffoni P, Re R, Zoppis E, Albano E, Bellomo G.
PMID: 10712828
Pharmacol Res. 2000 Jan;41(1):65-72. doi: 10.1006/phrs.1999.0553.

The effects of orally supplemented dl -alpha-tocopherol on the plasma concentration of lipid-soluble antioxidants and their distribution in very-low-density, low-density and high-density lipoproteins (VLDL, LDL and HDL) was investigated in a cohort of control normocholesterolemic adult subjects receiving 600...

Cite
Perugini C, Bagnati M, Cau C, et al. DISTRIBUTION OF LIPID-SOLUBLE ANTIOXIDANTS IN LIPOPROTEINS FROM HEALTHY SUBJECTS. II. EFFECTS OF IN VIVO SUPPLEMENTATION WITH alpha-TOCOPHEROL. Pharmacol Res. 2000;41(1):65-72doi: 10.1006/phrs.1999.0553.
Perugini, C., Bagnati, M., Cau, C., Bordone, R., Paffoni, P., Re, R., Zoppis, E., Albano, E., & Bellomo, G. (2000). DISTRIBUTION OF LIPID-SOLUBLE ANTIOXIDANTS IN LIPOPROTEINS FROM HEALTHY SUBJECTS. II. EFFECTS OF IN VIVO SUPPLEMENTATION WITH alpha-TOCOPHEROL. Pharmacological research, 41(1), 65-72. https://doi.org/10.1006/phrs.1999.0553
Perugini, et al. "DISTRIBUTION OF LIPID-SOLUBLE ANTIOXIDANTS IN LIPOPROTEINS FROM HEALTHY SUBJECTS. II. EFFECTS OF IN VIVO SUPPLEMENTATION WITH alpha-TOCOPHEROL." Pharmacological research vol. 41,1 (2000): 65-72. doi: https://doi.org/10.1006/phrs.1999.0553
Perugini C, Bagnati M, Cau C, Bordone R, Paffoni P, Re R, Zoppis E, Albano E, Bellomo G. DISTRIBUTION OF LIPID-SOLUBLE ANTIOXIDANTS IN LIPOPROTEINS FROM HEALTHY SUBJECTS. II. EFFECTS OF IN VIVO SUPPLEMENTATION WITH alpha-TOCOPHEROL. Pharmacol Res. 2000 Jan;41(1):65-72. doi: 10.1006/phrs.1999.0553. PMID: 10712828.
Copy Download .nbib Format: NLM
Alteration in plasma lipid profile in oral submucous fibrosis patients: A case control study.

South Asian journal of cancer

Kumar P, Singh A, Sankhla B, Naraniya A.
PMID: 24455599
South Asian J Cancer. 2013 Jul;2(3):147-9. doi: 10.4103/2278-330X.114134.

BACKGROUND: Lipids are major cell membrane components essential for various biological functions including cell growth and division of normal and malignant tissue. They are also required for maintenance of structural and functional integrity of all biological membranes. Alteration in...

Cite
Kumar P, Singh A, Sankhla B, et al. Alteration in plasma lipid profile in oral submucous fibrosis patients: A case control study. South Asian J Cancer. 2013;2(3):147-9doi: 10.4103/2278-330X.114134.
Kumar, P., Singh, A., Sankhla, B., & Naraniya, A. (2013). Alteration in plasma lipid profile in oral submucous fibrosis patients: A case control study. South Asian journal of cancer, 2(3), 147-9. https://doi.org/10.4103/2278-330X.114134
Kumar, Pramod, et al. "Alteration in plasma lipid profile in oral submucous fibrosis patients: A case control study." South Asian journal of cancer vol. 2,3 (2013): 147-9. doi: https://doi.org/10.4103/2278-330X.114134
Kumar P, Singh A, Sankhla B, Naraniya A. Alteration in plasma lipid profile in oral submucous fibrosis patients: A case control study. South Asian J Cancer. 2013 Jul;2(3):147-9. doi: 10.4103/2278-330X.114134. PMID: 24455599; PMCID: PMC3892529.
Copy Download .nbib Format: NLM
Comparative account of serum lipids, lipoproteins and apolipoprotein-B in patients of coronary artery disease.

Indian journal of clinical biochemistry : IJCB

Sharma R, Mahajan M, Kant R.
PMID: 23105418
Indian J Clin Biochem. 2004 Jan;19(1):10-3. doi: 10.1007/BF02872381.

Serum total lipids (cholesterol and triglyceride), lipoproteins (VLDL, LDL and HDL) and Apolipoprotein-B levels of normal healthy individuals (n=25) and coronary artery disease patients (n=25) were estimated. The objective of the present study was to ascertain the role of...

Cite
Sharma R, Mahajan M, Kant R. Comparative account of serum lipids, lipoproteins and apolipoprotein-B in patients of coronary artery disease. Indian J Clin Biochem. 2004;19(1):10-3doi: 10.1007/BF02872381.
Sharma, R., Mahajan, M., & Kant, R. (2004). Comparative account of serum lipids, lipoproteins and apolipoprotein-B in patients of coronary artery disease. Indian journal of clinical biochemistry : IJCB, 19(1), 10-3. https://doi.org/10.1007/BF02872381
Sharma, Ritu, et al. "Comparative account of serum lipids, lipoproteins and apolipoprotein-B in patients of coronary artery disease." Indian journal of clinical biochemistry : IJCB vol. 19,1 (2004): 10-3. doi: https://doi.org/10.1007/BF02872381
Sharma R, Mahajan M, Kant R. Comparative account of serum lipids, lipoproteins and apolipoprotein-B in patients of coronary artery disease. Indian J Clin Biochem. 2004 Jan;19(1):10-3. doi: 10.1007/BF02872381. PMID: 23105418; PMCID: PMC3453898.
Copy Download .nbib Format: NLM
Modalities of Empowerment and Strengthening of Ex-servicemen.

Medical journal, Armed Forces India

Harnagle R, Bhalwar R, Bhaskar SV.
PMID: 27365726
Med J Armed Forces India. 2010 Apr;66(2):138-41. doi: 10.1016/S0377-1237(10)80126-1. Epub 2011 Jul 21.

BACKGROUND: Older people including ex-servicemen (ESM) in India are left to fend for themselves due to nuclear family system. Most children are not staying with them due to reasons such as acquiring of education or employment at distant places....

Cite
Harnagle R, Bhalwar R, Bhaskar SV. Modalities of Empowerment and Strengthening of Ex-servicemen. Med J Armed Forces India. 2011;66(2):138-41doi: 10.1016/S0377-1237(10)80126-1.
Harnagle, R., Bhalwar, R., & Bhaskar, S. V. (2010). Modalities of Empowerment and Strengthening of Ex-servicemen. Medical journal, Armed Forces India, 66(2), 138-41. https://doi.org/10.1016/S0377-1237(10)80126-1
Harnagle, R, et al. "Modalities of Empowerment and Strengthening of Ex-servicemen." Medical journal, Armed Forces India vol. 66,2 (2010): 138-41. doi: https://doi.org/10.1016/S0377-1237(10)80126-1
Harnagle R, Bhalwar R, Bhaskar SV. Modalities of Empowerment and Strengthening of Ex-servicemen. Med J Armed Forces India. 2010 Apr;66(2):138-41. doi: 10.1016/S0377-1237(10)80126-1. Epub 2011 Jul 21. PMID: 27365726; PMCID: PMC4920910.
Copy Download .nbib Format: NLM
Serum lipid metabolism in psoriasis and psoriatic arthritis - an update.

Archives of medical science : AMS

Pietrzak A, Chabros P, Grywalska E, Kiciński P, Pietrzak-Franciszkiewicz K, Krasowska D, Kandzierski G.
PMID: 30899289
Arch Med Sci. 2019 Mar;15(2):369-375. doi: 10.5114/aoms.2018.74021. Epub 2018 Mar 08.

INTRODUCTION: Psoriasis and psoriatic arthritis (PSA) are chronic, inflammatory, systemic diseases characterized by metabolic abnormalities, including an increased cardiovascular risk and an oxidative imbalance. This study assessed blood parameters of lipid metabolism and markers of oxidative stress in patients...

Cite
Pietrzak A, Chabros P, Grywalska E, et al. Serum lipid metabolism in psoriasis and psoriatic arthritis - an update. Arch Med Sci. 2018;15(2):369-375doi: 10.5114/aoms.2018.74021.
Pietrzak, A., Chabros, P., Grywalska, E., Kiciński, P., Pietrzak-Franciszkiewicz, K., Krasowska, D., & Kandzierski, G. (2019). Serum lipid metabolism in psoriasis and psoriatic arthritis - an update. Archives of medical science : AMS, 15(2), 369-375. https://doi.org/10.5114/aoms.2018.74021
Pietrzak, Aldona, et al. "Serum lipid metabolism in psoriasis and psoriatic arthritis - an update." Archives of medical science : AMS vol. 15,2 (2019): 369-375. doi: https://doi.org/10.5114/aoms.2018.74021
Pietrzak A, Chabros P, Grywalska E, Kiciński P, Pietrzak-Franciszkiewicz K, Krasowska D, Kandzierski G. Serum lipid metabolism in psoriasis and psoriatic arthritis - an update. Arch Med Sci. 2019 Mar;15(2):369-375. doi: 10.5114/aoms.2018.74021. Epub 2018 Mar 08. PMID: 30899289; PMCID: PMC6425200.
Copy Download .nbib Format: NLM
Calculated Non-HDL Cholesterol Includes Cholesterol in Larger Triglyceride-Rich Lipoproteins in Hypertriglyceridemia.

Journal of the Endocrine Society

Sun CJ, McCudden C, Brisson D, Shaw J, Gaudet D, Ooi TC.
PMID: 32010872
J Endocr Soc. 2019 Nov 03;4(1):bvz010. doi: 10.1210/jendso/bvz010. eCollection 2020 Jan 01.

CONTEXT: Calculated non-high-density lipoprotein (HDL) cholesterol (non-HDLC) should selectively include cholesterol from atherogenic lipoproteins to be a reliable risk marker of cardiovascular disease. In hypertriglyceridemia (HTG), there is increased abundance of larger and less atherogenic triglyceride-rich lipoproteins (TRL), namely,...

Cite
Sun CJ, McCudden C, Brisson D, et al. Calculated Non-HDL Cholesterol Includes Cholesterol in Larger Triglyceride-Rich Lipoproteins in Hypertriglyceridemia. J Endocr Soc. 2019;4(1):bvz010doi: 10.1210/jendso/bvz010.
Sun, C. J., McCudden, C., Brisson, D., Shaw, J., Gaudet, D., & Ooi, T. C. (2020). Calculated Non-HDL Cholesterol Includes Cholesterol in Larger Triglyceride-Rich Lipoproteins in Hypertriglyceridemia. Journal of the Endocrine Society, 4(1), bvz010. https://doi.org/10.1210/jendso/bvz010
Sun, Cathy J, et al. "Calculated Non-HDL Cholesterol Includes Cholesterol in Larger Triglyceride-Rich Lipoproteins in Hypertriglyceridemia." Journal of the Endocrine Society vol. 4,1 (2020): bvz010. doi: https://doi.org/10.1210/jendso/bvz010
Sun CJ, McCudden C, Brisson D, Shaw J, Gaudet D, Ooi TC. Calculated Non-HDL Cholesterol Includes Cholesterol in Larger Triglyceride-Rich Lipoproteins in Hypertriglyceridemia. J Endocr Soc. 2019 Nov 03;4(1):bvz010. doi: 10.1210/jendso/bvz010. eCollection 2020 Jan 01. PMID: 32010872; PMCID: PMC6986683.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 59 entries